ev3 Inc. Earnings Conference Call (Q3 2009)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Oct 27 Calls Today's Calls

Call Details ev3 Inc. Earnings Conference Call (Q3 2009) Tue, Oct 27, 2009, 8:30 am Eastern Listen to the archived event audio About ev3 Inc. (NasdaqGS:EVVV) ev3 Inc. operates as an endovascular company that focuses on identifying and treating peripheral vascular disease, including lower extremity arterial disease and neurovascular disease. It develops, manufactures, and markets a range of products that include stents, atherectomy plaque excision products, thrombectomy and embolic protection devices, percutaneous transluminal angioplasty balloons, and other procedural support products for the peripheral vascular market. The company also offers embolic coils, liquid embolics, flow directed, and other micro catheters; occlusion balloon systems; guidewires; and neuro stents for the neurovascular market. It markets its products in the United States, Europe, and Canada through a direct sales force; and through distributors in other international markets. The company’s customers include a section of physicians, including interventional radiologists, neuroradiologists, vascular surgeons, neuro surgeons, endovascular specialists, and interventional cardiologists. ev3 Inc. was founded in 2000 and is headquartered in Plymouth, Minnesota. More Info: Quote | Profile | Reports | Research | Msgs | Insider | Financials | Analyst Ratings